DFX Intelligence
F-Prime Capital Partners Life Sciences Fund VII LP
As of · the latest observation of this vehicle; each figure below carries its own filing date
Active deploymentFundraising status unknownADV: Venture Capital Fund
As of · the latest observation of this vehicle; each figure below carries its own filing date
1 additional placement agent
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- -18%reported GAV
Reported gross assets fell from $736M to $606M between the Form ADV filings of 29 Mar 2024 and 26 Jun 2026.
The fund's assets as the adviser swears them, never its size or dry powder.
Drawing the relationship network…
Amounts, each with its basis
- Vintage
- 2022basis: adv first reported
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- unknownwhat may be sold, not what was raised
- Form D sold
- unknown
- First sale
- unknown
- Reported GAV
- $606Mon the Form ADV filed Jun 26, 2026; the fund's assets, never its size or dry powder
- Owners (ADV)
- 9
- Reported on ADV
- Mar 31, 2022 to Jun 26, 2026
Fundraising evidenceWhat counts as raisingA Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Unknown
no Form D or close on record (fr-1)
LifecycleActive deployment
vintage 2 to 4 years
age years: 4first sale: n/avintage year: 2022adv gav as of: Jun 26, 2026vintage basis: ADV first reportedform d sold: n/aform d offering: n/aform d latest filed at: n/a
The fund's own reporting through time
7 Form ADV filings
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | Venture Capital Fund | $520M | 3 | 75% | yes | ||
| Jun 28, 2022 | Venture Capital Fund | $520M | 3 | 75% | yes | ||
| Jan 30, 2023 | Venture Capital Fund | $520M | 3 | 75% | yes | ||
| Mar 31, 2023 | Venture Capital Fund | $694M | 3 | 75% | yes | ||
| Nov 30, 2023 | Venture Capital Fund | $694M | 3 | 75% | yes | ||
| Mar 29, 2024 | Venture Capital Fund | $736M | 3 | 75% | yes | ||
| Jun 26, 2026 | Venture Capital Fund | $606M | 9 | 97% |
Principals and agents
0 principals on Form D, 0 placement agents
No Form D related person on record.
Service providers
4 named on Form ADV Schedule D and Form D
- AuditorPwC · BOSTON, Massachusetts, United StatesForm ADV filed Jun 26, 2026 reports.adviserinfo.sec.gov
- CustodianCiti · NEW YORK, New York, United StatesForm ADV filed Jun 26, 2026 reports.adviserinfo.sec.gov
- CustodianNATIONAL FINANCIAL SERVICES LLC · JERSEY CITY, New Jersey, United StatesForm ADV filed Jun 26, 2026 reports.adviserinfo.sec.gov
Limited partners and their reported performanceWhose numbers these areEach row is the LP’s own number: its cash flows and its valuation policy as of its reporting date, not the fund’s. Net IRR is printed only when the LP prints one. The vintage is the LP’s definition (CalPERS: year of its first cash flow; WSIB: year of its initial investment).
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Known LPs and allocatorsWhat these amounts and dates areA commitment date prints only when the source printed one; otherwise the row carries the date of the report that listed it. A foundation’s 990-PF line is a holding at fair value on its return, never a commitment.
0 relationships, public pensions and the allocator graph, each counted once
No allocator names this vehicle in a public disclosure DFX holds: pension reports, foundation 990-PF returns or endowment disclosures.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
1 event
- Mar 31, 2022F-Prime Capital Partners Life Sciences Fund VII LP first reported on Form ADV by Impresa Management LLC (Venture Capital Fund), GAV $519,671,000Fund first reported on Form ADV Fact Form ADV
Evidence
0 observations
Every observation on this vehicle
Relationships across DFX
on 1 other DFX graph
Across the graphs
F-Prime Capital Partners Life Sciences Fund VII LP is the same institution as 1 record in RIA and Wealth.
RIA and Wealth1
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…
Record history
1 dated event on the change ledger, latest event first
- Fund first reported on ADV2022-03-31source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.